bronchiestasis treatment centers

Lung Institute Treatment Centers for Natural Bronchiectasis Therapy

The Lung Institute’s locations throughout the United States are the only cellular therapy centers in the world to focus solely on bronchiectasis and other chronic lung diseases. At the Lung Institute, we offer cellular therapy as a natural treatment option for a number of restrictive and obstructive lung diseases. More than 80 percent of our patients report seeing improvement in not only their condition, but also their overall quality of life, following cellular therapy.

When you visit one of our treatment centers seeking relief from symptoms associated with bronchiectasis, a dedicated Lung Institute doctor will work with you to determine the best form of therapy based on your specific condition. We offer two different forms of cellular therapy: venous (derived from the patient’s blood) and bone marrow (derived from the patient’s bone marrow). Both of these procedures:

  • Are performed on an outpatient basis over a period of two days
  • Utilize autologous cells, or cells derived from the patient’s own body, so there is virtually no risk of rejection
  • Are minimally invasive and require very little downtime, if any — most patients are able to return to their daily activities immediately following the procedure

Unlike traditional treatment options like medication or oxygen therapy, which only work to minimize symptoms of lung disease, cellular therapy has been shown to potentially relieve lung inflammation and slow the progression of the condition. And because our therapy uses cells taken directly from the patient, there is minimal risk of side effects.

If you would like to learn more about the cellular therapy our treatment centers offer for bronchiectasis patients, call the Lung Institute today at (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.